With effect from November 29, 2023, the units rights in Nasdaq will be traded on the list for First North Growth Market. Trading will continue up until and including December 08, 2023. Instrument: Unit rights Short name: BIOVIC UR Clearing: Bilateral settlement at Euroclear Sweden ISIN code: SE0021148145 Order book ID: 313255 Market Segment: First North STO Tick Size: MiFID II tick size table With effect from November 29, 2023, the paid subscription units in Biovica International AB will be traded on the list for First North Growth Market. Trading will continue up until further notice. Instrument: Paid subscription units Short name: BIOVIC BTU Clearing: Bilateral settlement at Euroclear Sweden ISIN code: SE0021148152 Order book ID: 313258 Market Segment: First North STO Tick Size: MiFID II tick size table For further information concerning this exchange notice please contact Issuer Surveillance, telephone +46 8 405 70 50, or iss@nasdaq.com Nasdaq Stockholm AB
Nasdaq Stockholm AB: Listing of unit rights and paid subscription units of Biovica International AB (158/23)
© 2023 GlobeNewswire
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 23.04. | Biovica International: Biovica Saves SEK 30 Million/Year and Investigates New Go-To Market Model in US | UPPSALA, SE / ACCESSWIRE / April 23, 2024 / Biovica International (STO:BIOVIC-B)(STO:BIOVIC.B)(FRA:9II) Biovica, active in blood-based cancer monitoring, announces a cost reduction program in Sweden... ► Artikel lesen | |
| 12.04. | Biovica International: DiviTum TKa in Observational Trial | UPPSALA, SWEDEN / ACCESSWIRE / April 12, 2024 / Biovica International (STO:BIOVIC-B)(STO:BIOVIC.B)(FRA:9II) Biovica, active in cancer monitoring, today announces that a observational trial with DiviTum... ► Artikel lesen | |
| 11.04. | Nomination Committee for Biovica International AB for the 2024 Annual General Meeting | UPPSALA, SWEDEN / ACCESSWIRE / April 11, 2024 / Biovica International (STO:BIOVIC-B)(STO:BIOVIC.B)(FRA:9II) The Nomination Committee prior to the 2024 Annual General Meeting will consist of three members... ► Artikel lesen | |
| 19.03. | Biovica International: Biovica rReceives Positive Patent Notification for Immunotherapies | UPPSALA, SE / ACCESSWIRE / March 19, 2024 / Biovica International (STO:BIOVIC-B)(STO:BIOVIC.B)(FRA:9II) Biovica, active in blood-based cancer monitoring, has received a positive International Preliminary... ► Artikel lesen | |
| 14.03. | Biovica International: Q3 Interim Report November-January 2023/2024 | UPPSALA, SE / ACCESSWIRE / March 14, 2024 / Biovica International (STO:BIOVIC-B)(STO:BIOVIC.B)(FRA:9II) Several new commercial agreements signed and evidence that DiviTum® TKa significantly improves... ► Artikel lesen |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen.
Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen,
bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen
Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu
verstehen sein kann.
